课题基金 / 基金详情

Identifying the mechanism of adverse inflammatory events induced by red blood cell antibody therapy in immune thrombocytopenia

Identifying the mechanism of adverse inflammatory events induced by red blood cell antibody therapy in immune thrombocytopenia
确定红细胞抗体治疗免疫性血小板减少症引起的不良炎症事件的机制
批准号:
449762
负责人:
Won Doyoon
金额:
$1.27万
依托单位:
依托单位国家:
加拿大
项目类别:
Studentship Programs
财政年份:
2020
资助国家:
加拿大
项目状态:
已结题
起止时间:
2020-12-01 至 2021-12-01

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Immune thrombocytopenia (ITP) is the most common bleeding disorder in children and the case number is continuously rising. This disease is characterized by an abnormally low level of platelets, a cell type that prevents blood loss by forming clots. Thus,
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金